Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 286.6 | 3.2 | 1.3 | 0.0 | 54.7 | 18.8 | 20.1 |
| Revenue growth | 8750.6% | 153.8% | | -100.0% | 191.0% | -6.3% | |
| Cost of goods sold | 0.0 | 1.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 286.6 | 1.6 | 1.2 | 0.0 | 54.7 | 18.8 | 20.1 |
| Gross margin | 100.0% | 50.0% | 91.1% | | 100.0% | 100.0% | 100.0% |
| Research and development | 239.1 | 252.9 | 132.8 | 69.6 | 33.4 | 31.9 | 30.7 |
| General and administrative | 47.5 | 38.1 | 26.1 | 16.7 | 12.5 | 7.7 | 7.2 |
| EBIT | -286.8 | -291.6 | -158.0 | -86.3 | 8.8 | -20.8 | -17.8 |
| EBIT margin | -100.1% | -9007.0% | -12385.8% | | 16.1% | -110.5% | -88.8% |
| Pre-tax income | -296.4 | -288.9 | -156.3 | -85.5 | 8.9 | -20.6 | -17.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -331.9 | -288.9 | -156.3 | -85.5 | 8.9 | -20.6 | -17.8 |
| Net margin | -115.8% | -8921.5% | -12245.6% | | 16.3% | -109.7% | -88.7% |
| |
| Diluted EPS | ($4.87) | ($4.95) | ($3.23) | ($2.11) | $0.30 | ($21.14) | ($19.54) |
| Shares outstanding (diluted) | 68.1 | 58.3 | 48.4 | 40.6 | 29.4 | 1.0 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|